{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:25:39Z","timestamp":1791192339360,"version":"4.1.0"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.3201\/eid2009.140142","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T15:57:26Z","timestamp":1406131046000},"page":"1498-1503","source":"Crossref","is-referenced-by-count":87,"title":["Passive Surveillance for Azole-Resistant<i>Aspergillus fumigatus<\/i>, United States, 2011\u20132013"],"prefix":"10.3201","volume":"20","author":[{"given":"Cau D.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2009.140142-201408120843-R1","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene.","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R2","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.","volume":"47","author":"Baddley","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R3","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India.","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R5","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.","volume":"54","author":"Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus, Iran.","volume":"19","author":"Seyedmousavi","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole.","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R8","unstructured":"European Centre for Disease Prevention and Control. Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles inAspergillusspecies [cited 2013 Dec 1]. http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?ID=823&List=4f55ad51%2D4aed%2D4d32%2Db960%2Daf70113dbb90"},{"key":"key-10.3201\/eid2009.140142-201408120843-R9","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1128\/JCM.00940-09","article-title":"Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R10","doi-asserted-by":"publisher","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health.","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2009.140142-201408120843-R11","doi-asserted-by":"crossref","unstructured":"Pham CD, Lockhart SR. An invisible threat: mutation-mediated resistance to triazole drugs inAspergillus.Current Fungal Infection Reports. 2012;6:288\u201395.","DOI":"10.1007\/s12281-012-0106-x"},{"key":"key-10.3201\/eid2009.140142-201408120843-R12","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/AAC.01358-10","article-title":"Aspergillus fumigatus strains with mutations in the cyp51a gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.","volume":"55","author":"Escribano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R14","doi-asserted-by":"crossref","unstructured":"Chowdhary A, Sharma C, Kathuria S, Hagen F, Meis JF. Azole-resistantAspergillus fumigatuswith the environmental TR46\/Y121F\/T289A mutation in India. [Epub ahead of print]. J Antimicrob Chemother. 2014;69:555\u20137.","DOI":"10.1093\/jac\/dkt397"},{"key":"key-10.3201\/eid2009.140142-201408120843-R15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis.","volume":"356","author":"Verweij","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2009.140142-201408120843-R16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.","volume":"52","author":"Denning","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R17","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/jac\/dks160","article-title":"High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR\/L98H, in a French cohort of patients with cystic fibrosis.","volume":"67","author":"Morio","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R18","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.","volume":"52","author":"Rodriguez-Tudela","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R19","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1128\/JCM.00335-12","article-title":"Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34\/L98H azole resistance mechanism.","volume":"50","author":"Camps","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R20","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.","volume":"49","author":"Mortensen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34\/L98H mutations in the cyp51A gene in Iran.","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"key-10.3201\/eid2009.140142-201408120843-R22","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2009.140142-201408120843-R23","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus.","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R24","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R25","doi-asserted-by":"publisher","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus.","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2009.140142-201408120843-R26","unstructured":"United States Department of Agriculture. Agricultural chemical usage [cited 2013 Nov 1]. http:\/\/usda.mannlib.cornell.edu\/MannUsda\/viewDocumentInfo.do;jsessionid=39589A84B623FFB18D319BF97277F79C?documentID=1560"},{"key":"key-10.3201\/eid2009.140142-201408120843-R27","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/JCM.41.3.1126-1129.2003","article-title":"In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.","volume":"41","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/jac\/dkq041","article-title":"Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands.","volume":"65","author":"Klaassen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R29","doi-asserted-by":"publisher","first-page":"14174","DOI":"10.1073\/pnas.231491298","article-title":"Regulation of cyclic peptide biosynthesis in a plant pathogenic fungus by a novel transcription factor.","volume":"98","author":"Pedley","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2009.140142-201408120843-R30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Disease Society of America.","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007\u20132009.","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure.","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2009.140142-201408120843-R33","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus cyp51A based on protein homology modeling.","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.","volume":"55","author":"Chen","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R35","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14alpha-sterol demethylase (cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs.","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1087-1845(02)00016-6","article-title":"Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate.","volume":"36","author":"Slaven","year":"2002","journal-title":"Fungal Genet Biol"},{"key":"key-10.3201\/eid2009.140142-201408120843-R38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1574-6968.2012.02575.x","article-title":"Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.","volume":"332","author":"Bowyer","year":"2012","journal-title":"FEMS Microbiol Lett"},{"key":"key-10.3201\/eid2009.140142-201408120843-R39","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1128\/AAC.48.11.4405-4413.2004","article-title":"In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance.","volume":"48","author":"da Silva Ferreira","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2009.140142-201408120843-R40","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/JCM.00308-13","article-title":"Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.","volume":"51","author":"Pfaller","year":"2013","journal-title":"J Clin Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/9\/14-0142_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:28:08Z","timestamp":1733286488000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/9\/14-0142_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2009.140142","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}